In the current study, we developed a 5-DMS (NPAS2, DAPK1, CNN3, FGFR2, PLEKHA5) signature diagnostic model and calculated GC diagnostic risk scores to accurately distinguish GC from normal tissues. The gene discussed is PLEKHA5; the disease is gastric cancer.